I suppose some will blame BTA mgmt for this.
Current BTA had nothing to do with Relenza licencing. In the industry 7%-10% is not a bad deal anywway for his type of thing.
We all know about the GSK/BTA court case. ABOBO/ peter crook keeps remionding us. Why rehash this again. WHY !!!
What good going forward does it bring. None.